Key facts
- It has raised $3.5M; the latest was Later Stage VC in Feb 2025.
- Notable investors include Shinhan Venture Investment, Murex Partners, DAYLI Partners, Ministry of SMEs and Startups, Seoul Business Agency — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for MediFab
- ·The full record, as it builds
Funding rounds
No funding rounds for MediFab are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MediFab
Developer of reconstruction and molding implants designed to replace silicone and fillers. The company develops biomaterials for tissue repair, alternative evaluation models for animal testing, and printing medical devices, providing clients with biomaterials for tissue restoration and 3D printing technology.
- Sector
- Business Products and Services (B2B)
- HQ
- Seoul, South Korea
- Founded
- 2016
- Employees
- 39
- Website
- imedifab.com/
- Ownership
- Privately Held (backing)
MediFab doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MediFab shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MediFab in its N-PORT filings yet. We sweep new filings monthly.